The UCLA Brain Research Institute, Semel Institute, and UCLA Cannabinoid Affinity Group are proud to present:
Join us for a historic series of talks from visiting speakers and UCLA faculty about the science of cannabis, cannabinoids, and the endocannnabinoid system, as we work towards the establishment of a world-class cannabis research program at UCLA.
Watch the presentations live on Facebook
Presentation and Topics:
9:00 am-9:10 am: Opening Remarks - Christopher Evans, PhD, Director, UCLA Brain Research Institute
9:15 am-9:55 am: Our Endocannabinoid System: Unique and Ubiquitous - Ken Mackie, MD, Professor of Psychological and Brain Sciences, Indiana University Bloomington
10:00 am-10:40 am: The Abuse and Therapeutic Potential of Cannabis - Ziva Cooper, PhD, Associate Professor of Clinical Neurobiology, Columbia University
10:45 am-11:05 am: Immunomodulatory Effects of Cannabis - Michael Roth, MD, Professor of Medicine, David Geffen School of Medicine at UCLA
11:10 am-11:30 am: Pulmonary Effects of Cannabis - Donald Tashkin, MD, Professor of Medicine, David Geffen School of Medicine at UCLA
11:35 am-11:55 am: Cannabidiol and Pediatric Epilepsy - Shaun Hussain, MD, Assistant Clinical Professor of Pediatric Neurology, David Geffen School of Medicine at UCLA
12:00 pm-12:15 pm: A Parent's Story of Cannabidiol and Pediatric Epilepsy - Ravi Aysola, MD, Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA & Rashmi Mullur, MD, Staff Endocrinologist, VA Greater Los Angeles & UCLA Gonda Diabetes Center
1:00 pm-1:20 pm: Addiction and Cannabis - Timothy Fong, MD, Associate Clinical Professor of Psychiatry, David Geffen School of Medicine at UCLA
1:25 pm-1:45 pm: Psychosis and Cannabis - Joseph Pierre, MD, Acting Chief, Inpatient Psychiatry, West Los Angeles VA Medical Center
1:50 pm-2:10 pm: Cannabis and Pain Management - Thomas Strouse, MD, Medical Director, Resnick Neuropsychiatric Hospital at UCLA
2:15 pm-2:35 pm: Synthetic Non-Psychoactive Cannabinoids for Chronic Pain - Igor Spigelman, PhD, Professor, Division of Oral Biology & Medicine, UCLA School of Dentistry
2:40 pm-3:00 pm: Accelerating Cannabis Research - Jeff Chen, MD/MBA Candidate, Co-Director, UCLA Cannabinoid Affinity Group
With the recent passage of Prop 64, California is now the largest population in the world with access to legal cannabis. Moreover, 20% of the US population has access to legal recreational cannabis, 60% has access to legal medical cannabis, and over 90% has access to some form of legal cannabis product (i.e. states have legalized the use of non-psychoactive cannabidiol derived from cannabis), all in defiance of the Federal Government's classification of cannabis as a "Schedule I drug".
Despite this unprecedented access, the science behind cannabis is sorely lacking—we simply do not know enough about the risks and therapeutic potential due to half a century of research restrictions.
This historic event will feature talks from visiting speakers and UCLA faculty on the science and their latest research regarding cannabis, cannabinoids, and the endocannnabinoid system, as we work towards the establishment of a world-class cannabis research program at UCLA.
Tags: Cancer, Cannabidiol, cannabis, Cannabis Research, Cardiology, Chronic Pain, Dentistry, Dr. Christopher Evans, Dr. Donald Tashkin, Dr. Igor Spigelman, Dr. Michael Roth, Dr. Ravi Aysola, Dr. Shaun Hussain, Dr. Thomas Strouse, Dr. Timothy Fong, endocannnabinoid system, Events, Immunomodulatory Effects of Cannabis, legal cannabis, medical cannabis, Mental Health, neurobiology, pediatric epilepsy, pediatric neurology, Prop 64, Psychoactive Cannabinoids, recreational cannabis, research, Research, Schedule I drug, Semel Institute, UCLA Brain Research Institute, UCLA Cannabinoid Affinity Group, UCLA School of Dentistry, Wellness